FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes

American Journal of Transplantation

Volumn 8, Issue 7, 2008, Pages 1423-1433

  Bunnag, S ^a   Allanach, K ^a   Jhangri, G S ^a   Sis, B ^a   Einecke, G ^a   Mengel, M ^a   Mueller, T F ^a   Halloran, P F ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Biopsy; FOXP3; Human; Kidney; mRNA expression; RT PCR; Transcript; Transplantation

Indexed keywords

HLA ANTIBODY; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; ATROPHY; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY FIBROSIS; KIDNEY GRAFT REJECTION; KIDNEY INJURY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; NEPHRITIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TREATMENT FAILURE; TREATMENT OUTCOME;

AGE FACTORS; BIOPSY, NEEDLE; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; GRAFT REJECTION; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY; TIME FACTORS;

EID: 47249084696     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02268.x     Document Type: Article

References (32)

1. Sakaguchi S, Sakaguchi N, Shimizu J et al. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: Their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001 182: 18 32.
2. Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 2007 8: 191 197.
3. Lahl K, Loddenkemper C, Drouin C et al. Selective depletion of Foxp3(+) regulatory T cells induces a scurfy-like disease. J Exp Med 2007 204: 57 63.
4. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003 3: 199 210.
5. Fehervari Z, Sakaguchi S. CD4(+) regulatory cells as a potential immunotherapy. Philos Transact Royal Soc B-Biol Sci 2005 360: 1647 1661.
6. Ziegler SF. FOXP3: Of mice and men. Ann Rev Immunol 2006 24: 209 226.
7. Walker MR, Kasprowicz DJ, Gersuk VH et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4(+)CD25(-) T cells. J Clin Invest 2003 112: 1437 1443.
8. Yagi H, Nomura T, Nakamura K et al. Crucial role of FOXP3 in the development and function of human CD25(+)CD4(+) regulatory T cells. Int Immunol 2004 16: 1643 1656.
9. Chikuma S, Bluestone JA. Expression of CTLA-4 and FOXP3 in cis protects from lethal lymphoproliferative disease. Eur J Immunol 2007 37: 1285 1289.
10. Sharma R, Jarjour WN, Zheng LJ, Gaskin F, Fu SM, Ju ST. Large functional repertoire of regulatory T-cell suppressible autoimmune T cells in scurfy mice. J Autoimmun 2007 29: 10 19.
11. Wildin RS, Freitas A. IPEX and FOXP3: Clinical and research perspectives. J Autoimmun 2005 25: 56 62.
12. Veronese F, Rotman S, Smith RN et al. Pathological and clinical correlates of FOXP3(+) cells in renal allografts during acute rejection. Am J Transplant 2007 7: 914 922.
13. Allan SE, Passerini L, Bacchetta R et al. The role of 2 FOXP3 isoforms in the generation of human CD4(+) Tregs. J Clin Invest 2005 115: 3276 3284.
14. Yagi H, Nomura T, Nakamura K et al. Crucial role of FOXP3 in the development and function of human CD25(+)CD4(+) regulatory T cells. Int Immunol 2004 16: 1643 1656.
15. Allan SE, Crome SQ, Crellin NK et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 2007 19: 345 354.
16. Muthukumar T, Dadhania D, Ding R et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005 353: 2342 2351.
17. Grimbert P, Mansour H, Desvaux D et al. The regulatory/cytotoxic graft-infiltrating T cells differentiate renal allograft borderline change from acute rejection. Transplant 2007 83: 341 346.
18. Bestard O, Cruzado JM, Mestre M et al. Achieving donor-specific hyporesponsiveness is associated with FOXP3(+) regulatory T cell recruitment in human renal allograft infiltrates. J Immunol 2007 179: 4901 4909.
19. Mueller TF, Einecke G, Reeve J et al. Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant 2007 7: 2712 2722.
20. Hidalgo LG, Einecke G, Allanach K et al. The transcriptome of human cytotoxic T cells: Measuring the burden of CTL-associated transcripts in human kidney transplants. Am J Transplant 2008 8: 637 646.
21. Famulski KS, Einecke G, Reeve J et al. Changes in the transcriptome in allograft rejection: IFN-g induced transcripts in mouse kidney allografts. Am J Transplant 2006 6: 1342 1354.
22. Famulski KS, Broderick G, Hay K et al. Transcriptome analysis reveals heterogeneity in the injury response of kidney transplants. Am J Transplant 2007 7: 2483 2495.
23. Einecke G, Broderick G, Sis B, Halloran PF. Early loss of renal transcripts in kidney allografts: Relationship to the development of histologic lesions and alloimmune effector mechanisms. Am J Transplant 2007 7: 1121 1130.
24. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999 55: 713 723.
25. Solez K, Colvin RB, Racusen LC et al. Banff '05 Meeting report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007 7: 518 526.
26. Haanstra KG, Wubben JA, Korevaar SS, Kondova I, Baan CC, Jonker M. Expression patterns of regulatory T-cell markers in accepted and rejected nonhuman primate kidney allografts. Am J Transplant 2007 7: 2236 2246.
27. Dijke IE, Velthuis JHL, Caliskan K et al. Intragraft FOXP3 mRNA expression reflects antidonor immune reactivity in cardiac allograft patients. Transplant 2007 83: 1477 1484.
28. Schwarz A, Mengel M, Gwinner W et al. Protocol biopsy program after renal transplantation: Structure and first results. Transpl Proc 2002 34: 2238 2239.
29. Nankivell BJ, Chapman JR. The significance of subclinical rejection and the value of protocol biopsies. Am J Transplant 2006 6: 2006 2012.
30. Stockinger B, Barthlott T, Kassiotis G. The concept of space and competition in immune regulation. Immunology 2004 111: 241 247.
31. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. Th17: An effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006 24: 677 688.
32. Carvalho-Gaspar M, Jones N, Luo S, Wood K. Location and time dictate the mechanism used by alloantigen-reactive CD25+CD4+ regulatory T cells to prevent rejection. American J Transpl World Transpl Cong 2006: 79.